The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes after stem cell boost for poor engraftment following allogeneic hematopoietic stem cell transplantation for patients with primary and secondary myelofibrosis.
 
Maria Leon-Camarena
No Relationships to Disclose
 
Leah Philips
No Relationships to Disclose
 
Colin Vale
Consulting or Advisory Role - Syndax
Research Funding - Cullinan Oncology; Incyte
 
Anthony Hunter
Consulting or Advisory Role - Blueprint Medicines; GlaxoSmithKline; Incyte; PharmaEssentia; Sobi? (formerly CTI biopharma)
Research Funding - Ascentage Pharma; Blueprint Medicines; Cogent Biosciences; Novartis; PharmaEssentia; Syntrix Biosystems
 
Joseph Rimando
No Relationships to Disclose
 
Michel Conn
No Relationships to Disclose
 
William Blum
No Relationships to Disclose
 
Edmund Waller
Stock and Other Ownership Interests - Cambium Medical Technologies; Cambium Medical Technologies
Honoraria - Allogene Therapeutics; AlloVir; Autolus; Gilead Company; Janssen Oncology; Novartis; Pharmacyclics; Sanofi; Verastem
Consulting or Advisory Role - Allogene,; AlloVir; BioLineRx; Cambium Medical Technologies; Novartis; Sanofi
Research Funding - BioLineRx; CSL Behring; Priothera; Sanofi; Verastem
Patents, Royalties, Other Intellectual Property - Receives royalties from patents on preparing platelet lysate that has been licensed to Cambium Medical Technologies
Travel, Accommodations, Expenses - Janssen Oncology
 
Amelia Langston
No Relationships to Disclose